Molecular evidence of engraftment in bone marrow after nonmyeloablative allogeneic stem cell transplant (NMASCT) is an unreliable indicator of residual/recurrent disease in the marrow.
Journal Article
Full Text
Duke Authors
Cited Authors
- Lagoo, AS; Gong, JZ; Rizzieri, DA; Stenzel, TT; Chao, NJ; Buckley, PJ
Published Date
- November 16, 2001
Published In
Volume / Issue
- 98 / 11
Start / End Page
- 185A - 185A
Published By
Pages
- 1
International Standard Serial Number (ISSN)
- 0006-4971
Language
- English